# Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the CrossBoss First Trial

Study · id `cardio:ct-nct02510547` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02510547](<https://clinicaltrials.gov/study/NCT02510547>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02510547

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 246 participants.

## Technical summary

Registry record NCT02510547. Randomized; single masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2017-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 246 participants (enrolled count; ClinicalTrials.gov record NCT02510547, source copy `cardio:ctgov-nct02510547-2018-01-25`, retrieved 2026-10-26)
- Start date: 2015-09 (registry gives no type) (ClinicalTrials.gov record NCT02510547, source copy `cardio:ctgov-nct02510547-2018-01-25`, retrieved 2026-10-26)
- Primary completion: 2017-08 (actual) (ClinicalTrials.gov record NCT02510547, source copy `cardio:ctgov-nct02510547-2018-01-25`, retrieved 2026-10-26)
- Completion: 2017-08 (actual) (ClinicalTrials.gov record NCT02510547, source copy `cardio:ctgov-nct02510547-2018-01-25`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02510547, source copy `cardio:ctgov-nct02510547-2018-01-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02510547-2018-01-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
- Condition: Arteriosclerosis
- Condition: Coronary Artery Disease
- Condition: Myocardial Ischemia
- Condition: Coronary Disease
- Intervention (Procedure): CrossBoss Catheter
- Intervention (Procedure): Antegrade Wire Escalation Strategy
- Lead sponsor: North Texas Veterans Healthcare System
- Lead sponsor class: FED
- Collaborator: Henry Ford Hospital
- Collaborator class: OTHER
- Collaborator: Massachusetts General Hospital
- Collaborator class: OTHER
- Collaborator: North Central Heart-Avera Sacred Heart Hospital
- Collaborator class: UNKNOWN
- Collaborator: Saint Lukes Hospital Mid America Heart Institute
- Collaborator class: UNKNOWN
- Collaborator: Missouri Heart Center
- Collaborator class: UNKNOWN
- Collaborator: University of Washington
- Collaborator class: OTHER
- Collaborator: Deborah Heart and Lung Center
- Collaborator class: OTHER
- Collaborator: Minneapolis Heart Institute
- Collaborator class: OTHER
- Collaborator: Wellspan Heart and Vascular
- Collaborator class: UNKNOWN
- Collaborator: United Heart and Vascular Clinic and United Hospital
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: North Texas Veterans Healthcare System (`cardio:org-north-texas-veterans-healthcare-system`)
- Registry lists this organization as a collaborator: Henry Ford Hospital (`cardio:org-henry-ford-hospital`)
- Registry lists this organization as a collaborator: Massachusetts General Hospital (`cardio:org-massachusetts-general-hospital`)
- Registry lists this organization as a collaborator: University of Washington (`cardio:org-university-of-washington`)

## Provenance

Content hash: feb0678ca6eb35af0d77cb5b54bb687fc3b5c994c9fd3191abbdeb88360cac55
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
